Tag Archives: SEAS

Best Dividend Stocks To Watch For 2018

ChannelAdvisor (NYSE: ECOM) and Tyler Technologies (NYSE:TYL) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

Institutional and Insider Ownership

Get ChannelAdvisor alerts:....More>>>

Top 10 Warren Buffett Stocks For 2018

Warren Buffett attends the world premiere screening of HBO’s “Becoming Warren Buffett” at The Museum of Modern Art on Thursday, Jan. 19, 2017, in New York. (Photo by Charles Sykes/Invision/AP)

Warren Buffett rarely likes technology stocks.

His rationale? Stick with what you know. Buffett readily admits that he does not understand technology so he has avoided investments....More>>>

Top 5 Clean Energy Stocks To Own For 2018

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-951753282&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/951753282/960×0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; A worker installs solar panels atop a house in the Netherlands. (Photo by Yuriko Nakao/Getty Images)

&l;p class=&q;tweet_line&q;&g;More than half a million jobs around the world....More>>>

Top Medical Stocks To Watch Right Now

This Top Pick for 2017 may very well have the best and broadest early-stage oncology pipeline with 12 drug development candidates, suggests Jay Silverman, editor The Medical Technology Stock Letter.

Incyte (INCY) is poised for a strong performance in 2017 that will be driven by three major catalysts.

The first is that the firm’s drug Jakafi will continue to be a compelling....More>>>

Top 10 Gold Stocks To Buy For 2018

U.S. equities finished mostly higher on Wednesday, with large caps stronger and small caps weaker, following the Federal Reserve’s latest policy announcement.

In the end, the Dow Jones Industrial Average gained 0.5%, the S&P 500 gained a fraction, the Nasdaq Composite gained 0.2% and the Russell 2000 lost 0.6%. Treasury bonds were stronger, the dollar weakened notably, gold lost....More>>>

best shares to invest in today

A top editor for the New York Times provided more than an hour of testimony on Wednesday, as a federal judge in Manhattan continues to weigh whether to proceed with Sarah Palin’s defamation lawsuit against the newspaper.

Fielding questions from attorneys representing both Palin and his paper, Times editorial page editor James Bennet detailed the writing and research behind a piece....More>>>

nyse penny stocks

Oil has been on a rollercoaster ride, making and stealing fortunes for and from speculators. Since mid-June, oil has plunged approximately 60%, which has been due to oversupply and slowing global economic growth, the latter of which leads to reduced demand. Earlier this year Feb. 11 to be exact oil hit a low of $26.05/barrel. Some economists and analysts feel as though the $30/barrel level can....More>>>

cheap penny stocks

As expected, the path of the S&P 500 in the first week of October 2016 came in below our standard model’s projections, as stock prices continued their mostly sideways trajectory of the last three months, although with a slightly downward course.

Click to enlarge

Coming into the week, investors appeared to be focusing their attention on the first quarter of 2017 in setting....More>>>

Top 10 Bank Stocks To Invest In 2017

We all know financial stocks have gone through the roof since President Trump’s win. So the question becomes: what do we do with these companies now?

There’s no one answer for every financial stock, of course.

Some are still great, undervalued buys—but there are two that have gotten grossly overvalued and should be avoided, or sold if you hold them. (Below, I’ll....More>>>

Top Biotech Stocks To Invest In 2017

BMO’s M. Ian Somaiya and team contend biotech stocks like Gilead Sciences (GILD) Amgen (REGN), Celgene (CELG) and Regeneron (REGN) might be bottoming–but that a bounce back probably won’t happen until the second half of the year. They explain why:

Reuters

The biotechnology industry has underperformed major market indices as growth for larger cap companies has....More>>>